Characterizing plasma NfL in a community‐dwelling multi‐ethnic cohort: Results from the HABLE study
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Introduction: No large‐scale characterizations of neurofilament light chain (NfL) have been conducted in diverse populations. Methods: Baseline data were analyzed among n = 890 Mexican Americans and n = 813 non‐Hispanic Whites from the multi‐ethnic Health & Aging Brain among Latino Elders (HABLE) study. Plasma NfL was measured on the Simoa platform. Results: In unadjusted models, NfL was significantly associated with age (P < .001), hypertension (P < .001), dyslipidemia (P = .02), and diabetes (P < .001). Covarying for age and sex, NfL was associated with neurodegeneration (P < .001) and global amyloid burden levels (P = .02) in a subset with available data. NfL levels were significantly associated with diagnostic groups (Normal Cognition [NC], mild cognitive impairment [MCI], Dementia; P < .001); however, there was no cut‐score that yielded acceptable diagnostic accuracy. NfL levels produced a sensitivity of 0.60 and specificity of 0.78 with negative predictive value of 89% for detecting amyloid positivity. Discussion: Plasma NfL levels are significantly impacted by age and medical co‐morbidities that are common among older adults, which complicate its utility as a diagnostic biomarker
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease
Mattsson, N., Andreasson, U., Zetterberg, H., Blennow, K., & Initiative, F. T. A. D. N. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.6117 · Cited by 1,070
Mattsson, N., Cullen, N. C., Andreasson, U., Zetterberg, H., & Blennow, K. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0765 · Cited by 726 · cited 2×
“This is in line with longitudinal work by Mattsson and colleagues, 16 who found longitudinal changes in NfL to be correlated with AD changes across measures of cognition as well as neuroimaging, and suggested its potential use as a marker for neurodegenerative progression.”
InfluentialCommunity-based participatory research as a tool to advance environmental health sciences
O'Fallon, L. R., & Dearry, A. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s2155 · Cited by 604 · cited 1×
“24–26 Here we examined data from the Health & Aging Brain among Latino Elders (HABLE) study to: (1) characterize the impact of demographic factors and medical co-morbidities on plasma NfL levels, (2) examine the link between plasma NfL and cognitive and neuroimaging outcomes, (3) determine if any…”
Babulal, G. M., Quiroz, Y. T., Albensi, B. C., Arenaza‐Urquijo, E., Astell, A. J., Babiloni, C., Bahar‐Fuchs, A., Bell, J., Bowman, G. L., Brickman, A. M., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.09.009 · Cited by 528
Self-citationA Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Blennow, K. (2017) · Neurology and Therapy · doi:10.1007/s40120-017-0073-9 · Cited by 295
Neurofilament relates to white matter microstructure in older adults
Moore, E. E., Hohman, T. J., Badami, F. S., Pechman, K. R., Osborn, K. E., Acosta, L. M. Y., Bell, S. P., Babicz, M. A., Gifford, K. A., Anderson, A. W., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.023 · Cited by 65 · cited 2×
“…work demonstrating a significant link between plasma NfL and MRI-based markers of neurodegeneration, as prior work has shown elevations in NfL to be associated with poorer white matter integrity (higher MD and lower FA), 40 although this has not been consistently found in cross-sectional work.”
Cited by
O'Bryant, S. E., Petersen, M., Hall, J., Johnson, L. A., & for the HABS‐HD Study Team (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12647 · Cited by 110
Self-citationContributors to Serum NfL Levels in People without Neurologic Disease
Fitzgerald, K. C., Sotirchos, E. S., Smith, M. D., Lord, H., DuVal, A., Mowry, E. M., & Calabresi, P. A. (2022) · Annals of Neurology · doi:10.1002/ana.26446 · Cited by 101
“associations between HbA1c and sNfL in a cohort of diabetics(27) as well as another study finding an association between higher plasma NfL and diabetes in a population of community dwelling older adults focusing on Alzheimer0s disease.(28) The specific mechanisms by which HbA1c is associated with higher sNfL levels is…”
Jiang, Y., Uhm, H., Ip, F. C., Ouyang, L., Lo, R. M. N., Cheng, E. Y. L., Cao, X., Tan, C. M. C., Law, B. C. H., Ortiz‐Romero, P., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13676 · Cited by 36
“64,65 Concordantly, our results show that patterns of the dysregulated blood proteome in AD differ between populations of Chinese and Europeandescent,particularlyinbiologicalpathwaysrelatedtoinflam-mation or vascular functions.”
BackgroundÁlvarez-Sánchez, L., Peña-Bautista, C., Ferré-González, L., Balaguer, A., Baquero, M., Casanova-Estruch, B., & Cháfer-Pericás, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021226 · Cited by 32
Metadata
- Authors
- O'Bryant, S., Petersen, M., Hall, J., Johnson, L., Yaffe, K., Braskie, M., Toga, A. W., Rissman, R. A., & for the HABLE study team
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2021-07-26
- Volume
- 18
- Issue
- 2
- Pages
- 240-250
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W3185540078
- Cited by
- 79
- References
- 8
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.